Subsequent attempt tyrosine kinase inhibitor discontinuation in patients with chronic myeloid leukemia; a single institute experience

Subsequent attempt tyrosine kinase inhibitor discontinuation in patients with chronic myeloid leukemia; a single institute experience

August 12, 2021 Leave a comment

Discontinuation of tyrosine kinase inhibitors (TKIs) is now a possible therapeutic aim for sufferers with continual section continual myeloid leukemia…

Continue Reading →